5.96
前日終値:
$6.01
開ける:
$5.98
24時間の取引高:
144.99K
Relative Volume:
1.42
時価総額:
$151.72M
収益:
-
当期純損益:
$-22.38M
株価収益率:
-4.227
EPS:
-1.41
ネットキャッシュフロー:
$-15.54M
1週間 パフォーマンス:
-0.75%
1か月 パフォーマンス:
-5.10%
6か月 パフォーマンス:
-30.09%
1年 パフォーマンス:
-3.72%
Nuvectis Pharma Inc Stock (NVCT) Company Profile
名前
Nuvectis Pharma Inc
セクター
電話
360-837-7232
住所
1 BRIDGE PLAZA, SUITE 275, FORT LEE
NVCT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
NVCT
Nuvectis Pharma Inc
|
5.96 | 153.00M | 0 | -22.38M | -15.54M | -1.41 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-02 | 開始されました | Maxim Group | Buy |
2025-03-17 | 開始されました | Laidlaw | Buy |
2022-07-13 | 開始されました | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc (NVCT) 最新ニュース
Technical analysis overview for Nuvectis Pharma Inc. stockJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Nuvectis Pharma (NASDAQ:NVCT) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Using flow based indicators on Nuvectis Pharma Inc.Oil Prices & Long-Term Growth Stock Strategies - newser.com
Applying Wyckoff theory to Nuvectis Pharma Inc. stockNew Guidance & Smart Allocation Stock Reports - newser.com
Published on: 2025-10-05 01:41:39 - newser.com
Price momentum metrics for Nuvectis Pharma Inc. explained2025 Key Lessons & Weekly Top Stock Performers List - newser.com
Using economic indicators to assess Nuvectis Pharma Inc. potential2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com
How to use Fibonacci retracement on Nuvectis Pharma Inc.Market Growth Review & Low Drawdown Investment Ideas - newser.com
Momentum divergence signals in Nuvectis Pharma Inc. chartJuly 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com
Using portfolio simulators with Nuvectis Pharma Inc. includedEarnings Growth Summary & Long-Term Safe Return Strategies - newser.com
Nuvectis Pharma Inc Stock Analysis and ForecastMarket Rumors and News & Market Trend Real-Time Reports - earlytimes.in
Goldman Sachs Group Inc. Takes $446,000 Position in Nuvectis Pharma, Inc. $NVCT - MarketBeat
What drives Nuvectis Pharma Inc stock priceTrading Volume Trends & Small Budget Trading Ideas - Early Times
Nuvectis Pharma (NASDAQ:NVCT) Shares Up 2.2%Time to Buy? - MarketBeat
Nuvectis Pharma (NASDAQ:NVCT) Shares Up 2.2% – Time to Buy? - Defense World
Nuvectis Pharma Appoints Juan Sanchez to Board - The Globe and Mail
Nuvectis Pharma adds former Intra-Cellular exec to board of directors - Investing.com Nigeria
Nuvectis Pharma adds former Intra-Cellular exec to board of directors By Investing.com - Investing.com South Africa
Nuvectis Pharma Appoints Juan Sanchez, MD, To Board - citybiz
Nuvectis Pharma Appoints Biotech Executive Juan Sanchez, MD, to the Board of Directors - GlobeNewswire
From $14.6B J&J Deal Success: Nuvectis Pharma Adds Key Biotech Executive to Board Ahead of Phase 1b Trial - Stock Titan
Is Nuvectis Pharma Inc. forming a reversal pattern2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
Nuvectis Pharma Inc (NVCT) 財務データ
収益
当期純利益
現金流量
EPS
Nuvectis Pharma Inc (NVCT) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Mosseri Marlio Charles | 10% Owner |
Jun 18 '25 |
Buy |
8.05 |
28,043 |
225,746 |
2,976,203 |
Mosseri Marlio Charles | 10% Owner |
Jun 17 '25 |
Buy |
8.11 |
5,399 |
43,786 |
2,948,160 |
Mosseri Marlio Charles | 10% Owner |
May 12 '25 |
Buy |
8.11 |
21,167 |
171,664 |
2,942,761 |
Mosseri Marlio Charles | 10% Owner |
May 06 '25 |
Buy |
8.59 |
12,444 |
106,955 |
2,896,565 |
Mosseri Marlio Charles | 10% Owner |
May 07 '25 |
Buy |
8.59 |
12,317 |
105,770 |
2,908,882 |
Mosseri Marlio Charles | 10% Owner |
May 08 '25 |
Buy |
8.65 |
2,650 |
22,922 |
2,911,532 |
Mosseri Marlio Charles | 10% Owner |
Feb 07 '25 |
Buy |
5.00 |
240,000 |
1,200,000 |
2,884,121 |
BENTSUR RON | Chairman & CEO |
Dec 24 '24 |
Buy |
4.65 |
4,500 |
20,925 |
3,270,924 |
Mosseri Marlio Charles | 10% Owner |
Dec 13 '24 |
Buy |
4.70 |
17,000 |
79,900 |
2,612,000 |
Poradosu Enrique | Chief Science & Business Off |
Nov 19 '24 |
Buy |
4.99 |
2,000 |
9,980 |
1,506,319 |
大文字化:
|
ボリューム (24 時間):